Stage 1 or stage 2 lung cancer: surgery, radiation and treatment afterward

Check how the early stage was established

Before treatment, staging uses the available scans and biopsy findings. Lymph nodes may need further assessment if the result would affect an operation. After surgery, examination of the removed tissue can reveal details that were not visible on imaging.

Ask whether the stated stage is clinical, based on the assessment before treatment, or pathological, based on surgical tissue. Also ask which staging edition is being used when comparing older reports. A change in the stage after surgery can explain why the team recommends medicines that were not part of the initial conversation.

Sources and references: [1]

Understand what the proposed operation removes

A lobectomy removes a lung lobe. A segmentectomy removes an anatomical part of a lobe and can be appropriate for selected small tumors. Other operations remove more or less tissue according to the tumor's location and surgical requirements. Lymph-node assessment forms part of cancer surgery.

Ask why the proposed extent of resection fits your tumor and how much breathing capacity you are expected to retain. A smaller incision and a smaller lung resection are different questions. Minimally invasive access describes how the surgeon reaches the chest, not necessarily how much lung is removed.

Sources and references: [1]

Separate surgical fitness from age alone

Breathing tests, exercise tolerance, heart health and other illnesses help estimate the risk of surgery. Tell the team what you can do on an ordinary day, including walking and climbing stairs. Previous chest surgery or radiation may also affect planning.

If an operation appears too risky, ask which risk is driving that conclusion and whether it can be improved. Smoking cessation, nutrition support and rehabilitation may be relevant before treatment. The team should also explain the alternative cancer treatment, so time spent preparing has a clear purpose.

Sources and references: [1]

When SBRT enters the discussion

SBRT delivers focused radiation in a limited number of sessions. It is commonly considered for medically inoperable early, node-negative NSCLC. The radiation plan depends on the tumor's size, movement with breathing and distance from structures such as major airways.

Potential effects include fatigue, inflammation in the lung and chest-wall discomfort. Central tumors need particular attention to dose and scheduling. If you are fit for an operation, discuss the strengths and uncertainties of choosing radiation instead, including how tissue diagnosis and lymph-node staging will be addressed.

Sources and references: [1]

Why medicine may come before surgery

Some resectable cancers with higher-risk features are treated with systemic therapy before surgery, sometimes as part of a plan that continues afterward. This can include chemotherapy with immunotherapy in eligible patients. Biomarker results, tumor size and nodal involvement influence suitability.

Ask the surgeon and oncologist to explain the shared sequence: how response will be assessed, when surgery will be reconsidered and what would change the plan. A recommendation for treatment first can be a planned part of curative care, rather than an indication that surgery has been ruled out.

Sources and references: [1]

Use the final pathology to decide on further treatment

Small, completely removed stage I cancers often proceed to surveillance without chemotherapy. Stage II disease more commonly leads to a discussion of postoperative platinum-based chemotherapy in patients fit enough to receive it. Tumor size, nodes, margins and prior therapy all matter.

Targeted treatment may be relevant for certain EGFR-mutated or ALK-positive cancers, while immunotherapy is used in selected settings. Ask about the expected benefit in your particular situation and how long treatment is planned. The drug name alone is not enough to explain a postoperative recommendation.

Sources and references: [1]

Plan recovery and surveillance together

Before discharge or the end of radiation, obtain instructions about activity, pain control and whom to call. New or increasing breathlessness, fever or significant bleeding requires prompt medical assessment. Your recovery schedule should leave room for the postoperative oncology visit if further treatment is being considered.

Follow-up imaging looks for recurrence and other changes in the remaining lung. Keep the original imaging files so future teams can compare scans directly. Ask which clinician owns the surveillance plan and how results will be shared if treatment and follow-up happen in different countries.

Sources and references: [1] [2]

Make a Shanghai consultation specific

If your question is whether surgery or SBRT better fits your circumstances, prepare both the cancer records and the lung-function results. EastMedGo can help organize an inquiry around that comparison using the lung cancer resources and relevant Shanghai hospital information.

Send the proposed operation, current stage and any preoperative treatment recommendation with your scans. We can help clarify appointment requirements and coordination arrangements. If surgery has already taken place, include the complete pathology report so the receiving team can address the postoperative decision without restarting the discussion from the first scan.

Common questions